Creative Biolabs Expands Immunology and Neuroscience Research Tools

New primary cell models and functional assays aim to address challenges in translational biology.

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

Creative Biolabs has expanded its portfolio of primary cell systems and functional assay tools, including primary macrophages, complement pathway assay kits, and primary neuronal models. The updates are designed to help drug developers address persistent challenges in translational biology, such as the gap between immortalized cell lines and complex, multicellular environments implicated in inflammation, neurodegeneration, and complement-driven pathology.

Why it matters

Macrophages, the complement system, and primary neurons are all critical areas of focus for biomedical research, but researchers have struggled with issues like batch-to-batch variability, inconsistent polarization, and the limitations of immortalized cell lines. Creative Biolabs' expanded offerings aim to provide more reliable and physiologically relevant models to support drug discovery and development in these important fields.

The details

Creative Biolabs' macrophage offering now includes primary macrophages, subtype-defined populations, and polarization-ready models validated for responsiveness to key stimuli. Their complement assay kit suite spans the classical, lectin, and alternative pathways, optimized for sensitivity and reproducibility. And their primary neuron portfolio includes cortical, hippocampal, dopaminergic, and sensory neurons, validated for synaptic marker expression and long-term culture stability.

  • Creative Biolabs announced the portfolio expansion on February 27, 2026.

The players

Creative Biolabs

A life science research tools and services provider supporting global biomedical innovation.

Principal Investigator at a Mid-Size Biotech

A researcher who described the improved consistency of Creative Biolabs' primary macrophage models compared to their previous approaches.

Early-Stage Biotech Scientist

A researcher who noted the reproducibility of Creative Biolabs' complement assay kits as the main reason for switching to their products.

Neurobiology Group

Researchers evaluating complement-mediated synapse loss who commented on the consistency of Creative Biolabs' primary neuron models.

Got photos? Submit your photos here. ›

What they’re saying

“We were seeing too much drift in our macrophage polarization assays. The primary models from Creative Biolabs gave us more consistent cytokine profiles across replicates, which helped stabilize our screening workflow.”

— Principal Investigator at a Mid-Size Biotech

“We needed a kit that could reliably detect partial inhibition in the alternative pathway. The reproducibility across runs was the main reason we switched.”

— Early-Stage Biotech Scientist

“The consistency in synaptic density across batches allowed us to run multi-week pruning assays without recalibrating our baseline each time.”

— Neurobiology Group

The takeaway

Creative Biolabs' expanded portfolio of primary cell models and functional assays aims to help biomedical researchers overcome persistent challenges in translational biology, providing more reliable and physiologically relevant tools to support drug discovery and development in key areas like inflammation, neurodegeneration, and complement-driven pathology.